Indoco Remedies Limited (INDOCO.BO)
- Previous Close
324.45 - Open
332.20 - Bid 327.80 x --
- Ask 328.75 x --
- Day's Range
325.25 - 332.20 - 52 Week Range
308.80 - 416.95 - Volume
4,911 - Avg. Volume
5,433 - Market Cap (intraday)
30.276B - Beta (5Y Monthly) 0.42
- PE Ratio (TTM)
29.84 - EPS (TTM)
11.01 - Earnings Date May 21, 2024 - May 25, 2024
- Forward Dividend & Yield 2.25 (0.68%)
- Ex-Dividend Date Sep 18, 2023
- 1y Target Est
189.13
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infective, vitamin/mineral/nutrient, ophthal/ontological, antifungal, hormonal, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; anti-haemorrhoidals; antacids; antihistaminic; etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom synthesis of molecules and intermediates, process chemistry research and development, non-infringing process designing and scale up, and analytical method development/validation solutions, as well as contract manufacturing services. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
www.indoco.com6,000
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: INDOCO.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INDOCO.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INDOCO.BO
Valuation Measures
Market Cap
30.28B
Enterprise Value
34.40B
Trailing P/E
29.86
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.70
Price/Book (mrq)
2.83
Enterprise Value/Revenue
1.94
Enterprise Value/EBITDA
13.25
Financial Highlights
Profitability and Income Statement
Profit Margin
5.66%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
17.96B
Net Income Avi to Common (ttm)
1.02B
Diluted EPS (ttm)
11.01
Balance Sheet and Cash Flow
Total Cash (mrq)
682.5M
Total Debt/Equity (mrq)
46.34%
Levered Free Cash Flow (ttm)
--
Research Analysis: INDOCO.BO
Company Insights: INDOCO.BO
INDOCO.BO does not have Company Insights